Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Janssen

Showing results (11-20 of 433) with videos related to

Pageof 44
Sort By:
Revue Medicale De Bruxelles|December 1, 1980
Drug researchP A Janssen
Advances in Biochemical Psychopharmacology|January 1, 1973
Potent long-acting antagonists of the 9,9-dialkylbenzomorphan seriesP A Janssen
Acta Psiquiatrica Y Psicologica De America Latina|December 1, 1979
[Psychopharmacology of haloperidol]P A Janssen
Modern Problems of Pharmacopsychiatry|January 1, 1970
Chemical and pharmacological classification of neurolepticsP A Janssen
Journal of Clinical Pharmacology|May 1, 1991
Levamisole as an adjuvant in cancer treatmentP A Janssen
Journal of the Royal Society of Medicine|July 1, 1987
Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?P A Janssen
Endeavour|January 1, 1985
Strategies in pharmaceutical researchP A Janssen
AWHONN Lifelines|March 20, 2002
Silicone breast implants. What do we know about their long-term effects?B Arthur, P A Janssen
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Experimental aspergillosisJ Van Cutsem, P A Janssen
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1981
Factors regulating drug cue sensitivity: the effect of frustrative non-reward in fentanyl-saline discriminationF C Colpaert, P A Janssen
Pageof 44

Showing results (11-20 of 433) with videos related to

Sort By:
Pageof 44
Revue Medicale De Bruxelles|December 1, 1980
Drug researchP A Janssen
Advances in Biochemical Psychopharmacology|January 1, 1973
Potent long-acting antagonists of the 9,9-dialkylbenzomorphan seriesP A Janssen
Acta Psiquiatrica Y Psicologica De America Latina|December 1, 1979
[Psychopharmacology of haloperidol]P A Janssen
Modern Problems of Pharmacopsychiatry|January 1, 1970
Chemical and pharmacological classification of neurolepticsP A Janssen
Journal of Clinical Pharmacology|May 1, 1991
Levamisole as an adjuvant in cancer treatmentP A Janssen
Journal of the Royal Society of Medicine|July 1, 1987
Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?P A Janssen
Endeavour|January 1, 1985
Strategies in pharmaceutical researchP A Janssen
AWHONN Lifelines|March 20, 2002
Silicone breast implants. What do we know about their long-term effects?B Arthur, P A Janssen
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Experimental aspergillosisJ Van Cutsem, P A Janssen
Archives Internationales De Pharmacodynamie Et De Therapie|December 1, 1981
Factors regulating drug cue sensitivity: the effect of frustrative non-reward in fentanyl-saline discriminationF C Colpaert, P A Janssen
Pageof 44